{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:07:27Z","timestamp":1787238447350,"version":"build-2736575974"},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,31]]},"DOI":"10.18632\/oncotarget.8999","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T08:25:34Z","timestamp":1461659134000},"page":"32652-32663","source":"Crossref","is-referenced-by-count":18,"title":["Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3"],"prefix":"10.18632","volume":"7","author":[{"given":"Peipei","family":"Yang","sequence":"first","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicai","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Li","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Eilers","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"He","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Ou","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China"},{"name":"Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang, China"},{"name":"Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<14::AID-PATH730>3.0.CO;2-O","article-title":"Distinct mdm2\/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms","volume":"181","author":"Pierotti","year":"1997","journal-title":"J Pathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1078-0432.CCR-10-2050","article-title":"Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis","volume":"17","author":"Thomas","year":"2011","journal-title":"Clin Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","article-title":"p53 ubiquitination: Mdm2 and beyond","volume":"21","author":"Gu","year":"2006","journal-title":"Mol Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.274.5289.948","article-title":"Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain","volume":"274","author":"Pavletich","year":"1996","journal-title":"Science"},{"key":"5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-2836(02)00852-5","article-title":"Molecular mechanism of the interaction between MDM2 and p53","volume":"323","author":"Fersht","year":"2002","journal-title":"J Mol Biol"},{"key":"6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc991","article-title":"Inhibiting the p53-MDM2 interaction: an important target for cancer therapy","volume":"3","author":"Chene","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by Mdm2","volume":"387","author":"Vousden","year":"1997","journal-title":"Nature"},{"key":"8","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1158\/0008-5472.CAN-14-1446","article-title":"MDM2-p53 pathway in hepatocellular carcinoma","volume":"74","author":"Zhang","year":"2014","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1073\/pnas.0507493103","article-title":"Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy","volume":"103","author":"Vassilev","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jnci\/djp355","article-title":"Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53","volume":"101","author":"De","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"11","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.18632\/oncotarget.3230","article-title":"HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status","volume":"6","author":"Fletcher","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.18632\/oncotarget.3116","article-title":"Identifying the determinants of response to MDM2 inhibition","volume":"6","author":"Oliner","year":"2015","journal-title":"Oncotarget"},{"key":"13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nm0896-912","article-title":"Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer","volume":"2","author":"Lunec","year":"1996","journal-title":"Nat Med"},{"key":"14","first-page":"3212","article-title":"Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer","volume":"61","author":"Press","year":"2001","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1038\/sj.onc.1204533","article-title":"An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2","volume":"20","author":"Lozano","year":"2001","journal-title":"Oncogene"},{"key":"16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/labinvest.2013.107","article-title":"andstudies of MDM2\/MDMX isoforms predict Nutlin-3A sensitivity in well\/de-differentiated liposarcomas","volume":"93","author":"Maestro","year":"2013","journal-title":"Lab Invest"},{"key":"17","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1038\/sj.onc.1209282","article-title":"Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control","volume":"25","author":"Piris","year":"2006","journal-title":"Oncogene"},{"key":"18","first-page":"5703","article-title":"Tumor promotion by Mdm2 splice variants unable to bind p53","volume":"63","author":"Lowe","year":"2003","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1074\/jbc.M305966200","article-title":"An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis","volume":"279","author":"Jones","year":"2004","journal-title":"J Biol Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ijc.1399","article-title":"Inhibition of estrogen-dependent breast cell responses with phenylacetate","volume":"93","author":"Sidell","year":"2001","journal-title":"Int J Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/sj.onc.1205293","article-title":"Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells","volume":"21","author":"Straus","year":"2002","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Oren","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-12-2807","article-title":"MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models","volume":"73","author":"Podlaski","year":"2013","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1535-7163.MCT-14-0710","article-title":"The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents","volume":"14","author":"Kaufman","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2005.10.017","article-title":"MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein","volume":"20","author":"Xiao","year":"2005","journal-title":"Mol Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1038\/onc.2015.11","article-title":"MDMX exerts its oncogenic activity via suppression of retinoblastoma protein","volume":"34","author":"Xiao","year":"2015","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/onc.2008.423","article-title":"Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells","volume":"28","author":"Reddy","year":"2009","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1593\/neo.101156","article-title":"Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma","volume":"13","author":"Fletcher","year":"2011","journal-title":"Neoplasia"},{"key":"29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/onc.2010.555","article-title":"AXL regulates mesothelioma proliferation and invasiveness","volume":"30","author":"Fletcher","year":"2011","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.V74.3.940.940","article-title":"Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines","volume":"74","author":"Griffin","year":"1989","journal-title":"Blood"},{"key":"31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/path.2564","article-title":"c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme","volume":"218","author":"Fletcher","year":"2009","journal-title":"J Pathol"},{"key":"32","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1038\/onc.2008.177","article-title":"Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors","volume":"27","author":"Fletcher","year":"2008","journal-title":"Oncogene"},{"key":"33","first-page":"8118","article-title":"KIT Activation Is a Ubiquitous Feature of Gastrointestinal Stromal Tumors","volume":"61","author":"Fletcher","year":"2001","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1525-1578(10)60704-0","article-title":"Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas","volume":"4","author":"Medeiros","year":"2002","journal-title":"J Mol Diagn"},{"key":"35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1073\/pnas.0405495102","article-title":"The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma","volume":"102","author":"Shohet","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.18388\/abp.2006_3348","article-title":"Quantitative analysis of the level of p53 and p21(WAF1) mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate","volume":"53","author":"Dzierzewicz","year":"2006","journal-title":"Acta Biochim Pol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:10:25Z","timestamp":1589217025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":36,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,5,31]]}},"alternative-id":["8999","27129163"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8999","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]}}}